Who Should Avoid Salmon DNA? Absolute and Temporary Limits

The answer to who should avoid salmon DNA falls into two headings: cases where the treatment is not carried out at all, and cases where the session is postponed. That distinction makes a practical difference; in one the path is closed, in the other only the timing changes. This article separates the two groups.

Allergy to fish-derived products

Short answer: Where there is a known allergy to fish or fish-derived products this treatment is not carried out. That limit is specific to this product and is not negotiated.

The reason is the source of the product. Polynucleotides are purified from salmon, and although they go through purification processes the source does not change.

The severity of an allergic response cannot be predicted. Having had a mild response before does not mean the next encounter will be mild.

That uncertainty is not one to take on for a cosmetic treatment; salmon DNA and fish allergy is covered separately.

Pregnancy and breastfeeding

Treatments of this kind for cosmetic purposes are not carried out during pregnancy and breastfeeding. That limit comes not from proven harm but from not taking on an unnecessary uncertainty.

The changes in the body already affect appearance in these periods and the picture has not settled. An early assessment can be misleading.

Where a pregnancy is planned that should be mentioned at the consultation too. If the process spreads across a series, the calendar has to be built around it.

Postponing a cosmetic treatment costs nothing. Because there is no medical necessity the equation is easy to strike.

An active problem in the area

Where there is active infection, an inflamed skin condition or an open wound in the treatment area, the session is not carried out. This is a temporary barrier.

The reason is clear: a treatment involving injection can carry an existing infection into deeper tissue.

The same logic applies to conditions such as eczema or active acne in the area. These are not permanent barriers but reasons to postpone.

Where another procedure has recently been performed in the area, waiting also applies; the tissue needs to settle.

Autoimmune conditions

The treatment is not carried out during an active phase of an autoimmune condition. That is a heading requiring the picture itself to be assessed.

Where the condition is under control the decision is not made alone; the assessment of the doctor running that treatment is taken.

That is not presented as an obstacle. The right order is set and the process runs alongside where needed.

Bleeding and clotting

Short answer: The treatment is not carried out in people with a bleeding disorder; in those taking blood thinners the decision is not made alone and whether the medicine can be stopped is a decision for the doctor who prescribed it.

Treatment is never altered on its own account for a cosmetic procedure. That is one of the headings where the order is not disturbed.

Aspirin, some painkillers and herbal supplements can also increase the tendency to bleed, which is why supplements have to be included in the medication list; the side effect headings are gathered separately.

If the expectation sits outside the limit

Where the source of the complaint is volume loss rather than tissue quality the treatment is not medically prohibited, but it is not recommended because it will not deliver the expected result. That too is a limit.

The distinction is made at examination and looking is not enough; how polynucleotides work covers that mechanism.

Saying "let us try" in an unsuitable picture costs someone time and an unnecessary procedure. In mixed pictures the question becomes "how much of it does this solve" rather than "can it be done".

Why are these asked at the outset?

Short answer: An approach that offers treatment without going through this list should read as a warning sign. The questions decide the outcome; an incomplete answer loads the risk onto you alone.

Some of them are personal and can feel intrusive. They still have to be answered fully; the only reason they are asked is safety.

Information emerging later means a planned session is cancelled. That is the correct decision rather than a setback.

Being able to verify that the product is licensed belongs here too; in Türkiye licensing is handled by TİTCK. The treatment's own page sits under salmon DNA.

Frequently asked questions

I take a blood thinner — can it be done? It is not an automatic barrier, but the decision is not made alone. Whether the medicine can be stopped depends on the assessment of the doctor who prescribed it, and treatment is never altered on its own account for a cosmetic procedure. That information must be shared at the consultation.

I have an autoimmune condition — is that a barrier? It is not carried out during an active phase. Where the condition is under control the decision is not made alone; the assessment of the doctor running that treatment is taken and the process runs alongside where needed. That is handled as the right order rather than as an obstacle.

I have stopped breastfeeding — can I have it straight away? Once breastfeeding ends the treatment can come onto the agenda, but a further waiting period is discussed. The changes in the body already affect appearance in this period, so the picture is allowed to settle; an early assessment can be misleading.

Is there an age limit? What decides is not age but the state of the picture and the source of the complaint. If no complaint relating to tissue quality is described the treatment has nothing to act on. Deciding not to treat is a valid outcome and worth more than recommending a procedure that will not deliver.

---

If you would like to talk through whether there is a barrier in your own picture, the consultation reviews your health history and the area together.

This article is for general information and is not medical advice. Assessment and treatment decisions follow a medical examination; results vary between individuals.